Related Experiment Video
Updated: Feb 24, 2026
05:59
Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
Published on: October 20, 2023
3.2K
Sleep Disorders: Insomnia
1Latterman Family Health Center, 2347 Fifth Ave, McKeesport, PA 15132.
FP Essentials
|August 29, 2017
Summary
Insomnia, a common sleep disorder, significantly impacts health. Cognitive Behavioral Therapy for Insomnia (CBT-I) is effective, but access to trained clinicians remains a challenge for this public health issue.
Area of Science:
- Family Medicine
- Sleep Medicine
- Public Health
Background:
- Insomnia is the most prevalent sleep disorder in family medicine.
- It presents as difficulty initiating/maintaining sleep or nonrestorative sleep, causing daytime impairment.
- Insomnia is a significant public health concern due to its high prevalence and complex management.
Purpose of the Study:
- To review the diagnosis and treatment of insomnia.
- To highlight the association between insomnia and comorbidities.
- To discuss current and emerging pharmacotherapies.
Main Methods:
- Review of sleep history, including sleep diaries for accurate pattern assessment.
- Evaluation of Cognitive Behavioral Therapy for Insomnia (CBT-I) as a primary treatment.
- Discussion of pharmacotherapy options, including nonbenzodiazepines and newer agents.
Main Results:
- A thorough sleep history is crucial for diagnosis and treatment planning.
- Cognitive Behavioral Therapy for Insomnia (CBT-I) is a safe and effective treatment, though clinician availability is limited.
- Pharmacotherapy, including newer agents, is used for chronic insomnia, but treatment guidelines are still evolving.
Conclusions:
- Insomnia requires comprehensive assessment and management strategies.
- CBT-I is the recommended first-line treatment, emphasizing the need for increased clinician training.
- Further research and clear guidelines are necessary for optimizing pharmacotherapy for chronic insomnia.
More Related Videos
06:23A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
Published on: September 22, 2020
6.1K
08:36Collecting Sleep, Circadian, Fatigue, and Performance Data in Complex Operational Environments
Published on: August 8, 2019
12.9K
Related Concept Videos
01:27Insomnia
513
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
513
01:24Sleep-Wake Cycles
3.1K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
3.1K
01:19Management of Insomnia
732
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
732
01:17Sleepwalking and Sleep Talking
1.1K
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
1.1K
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
682
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
682
01:07Narcolepsy
610
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
610